Back to state act
Description
On 19 December 2025, the U.S. Administration announced reaching an agreement with Genentech. Under the agreement, Genentech will be exempt from potential Section 232 tariffs on pharmaceutical products...
Sign in to see full description
Intervention Details
Intervention Type
Tax or social insurance relief
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
31 Jul 2026
Revocation date
20 Jan 2029
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 5 products
Threads
See all
This intervention is not part of any Thread yet.